Crowdsourcing brings some festive cheer to MSers

"Some festive cheer! Larry Steinman and colleagues have just been given the green light by the FDA to run an innovative trial of the hypertension drug lisinopril in MS. What is interesting about this trial is that the trial was designed  using novel crowd sourcing software." 

"The company running the trial Transparency Life Sciences, had its Investigational New Drug Application (IND) to assess lisinopril as an adjunctive therapy for MS cleared by the FDA. The trial will use telemonitoring and remote methods for MSer data collection."

Karry Steinman, is the chair of the Scientific Advisory Board, noted, 'Our preclinical data confirms the role of the angiotensin system in the pathology of MS and provides evidence that the ACE inhibitor lisinopril can modulate those effects in target-specific ways. We are delighted that this novel clinical trial protocol has been cleared by the FDA, enabling us to test whether these preclinical findings can translate into a safe and affordable new therapeutic option for MS patients.'


Source: FierceBiotech

"Could this be a way of doing studies of other off-patent drugs? Is this the beginning of the BPA revolution?"

"Happy Holidays"

Labels: , ,